LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 24 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,086,709 | +1.8% | 3,117,000 | 0.0% | 0.19% | +101.0% |
| Q4 2022 | $3,033,231 | +0.6% | 3,117,000 | 0.0% | 0.10% | +31.5% |
| Q3 2022 | $3,016,000 | +1.0% | 3,117,000 | 0.0% | 0.07% | +5.8% |
| Q2 2022 | $2,985,000 | +162.5% | 3,117,000 | +166.4% | 0.07% | +165.4% |
| Q1 2022 | $1,137,000 | -81.8% | 1,170,000 | -82.3% | 0.03% | -93.3% |
| Q4 2020 | $6,232,000 | – | 6,623,000 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 64,118,000 | $55,709,000 | 4.91% |
| SYMPHONY ASSET MANAGEMENT LLC | 9,000,000 | $7,790,000 | 1.72% |
| CANYON CAPITAL ADVISORS LLC | 65,000,000 | $56,160,000 | 1.31% |
| CAMDEN ASSET MANAGEMENT L P /CA | 44,450,000 | $38,362,000 | 1.24% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 60,954,000 | $52,832,000 | 1.02% |
| Context Capital Management, LLC | 2,350,000 | $2,028,000 | 1.02% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,160,000 | $3,622,000 | 0.47% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 22,500,000 | $19,418,000 | 0.44% |
| OAKTREE CAPITAL MANAGEMENT LP | 23,903,000 | $20,688,000 | 0.39% |
| WOLVERINE ASSET MANAGEMENT LLC | 36,633,000 | $31,784,000 | 0.37% |